Behavioral Health Tech Video Library

Cynthia Kilroy

Co-CEO, Genomind

As Chief Strategy and Corporate Development Officer, Ms. Kilroy is responsible for the development of the corporate strategy to develop a behavioral health ecosystem through partnerships and acquisitions to drive the growth of Genomind.

Prior to Genomind, Ms. Kilroy has a long history as a healthcare leader with executives including Senior Vice President of Provider Strategy for Optum Accountable Care, Vice President of Strategy and Acquisitions, Healthcare for Cognizant Technology Solutions and CEO of Bolder Healthcare Solutions, a Cognizant Company. Cynthia was founder of CCK Consulting, a strategic advisory company for health care provider and payer organizations, entrepreneurs, start-ups, and private equity companies. Here, she specialized in re-configuring markets and helping companies navigate the transition to digital healthcare and compete on health system value.

Cynthia is active in numerous industry and community organizations. She currently serves as a strategic advisor to Decode Healthcare and Siris Medical. She served as a Board Member of St. Francis Hospital in San Francisco, leading the strategic planning committee.

Cynthia received her MBA from Duke University, Fuqua School of Business with a certification in Health Sector Management. She is a graduate of DeSales University with a degree in Computer Science.

Dr. David Krause

Co-CEO & Chief Medical Officer, Genomind

Dr. David Krause is Co-Chief Executive Officer and Chief Medical Officer at Genomind. Board certified in internal medicine, Dr. Krause has more than 25 years of experience in pharmaceutical research and development and medical affairs. At Genomind, he is responsible for clinical research and serves as liaison to the community of Genomind's patients, customers and subject matter experts. Prior to joining Genomind, Dr. Krause was the head of several global therapeutic areas at SmithKline Beecham and GlaxoSmithKline. He was also Chief Medical Officer at Vicuron Pharmaceuticals, which was acquired by Pfizer, Inc. in 2006.

Dr. Krause is a Fellow of the American College of Physicians, and author of more than 40 scientific publications and abstracts, and has served as a consultant to the Department of Defense.

Dr. Krause is a graduate of the Pennsylvania State University, where he was named a Centennial Fellow by the College of Liberal Arts, and received his MD degree from Temple University.